Cargando…
The Pricing of Breakthrough Drugs: Theory and Policy Implications
Pharmaceutical sales exceed $850 billion a year, of which 84% are accounted for by brand drugs. Drug prices are the focus of an ongoing heated debate. While some argue that pharmaceutical companies exploit monopolistic power granted by patent protection to set prices that are “too high”, others clai...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244177/ https://www.ncbi.nlm.nih.gov/pubmed/25422889 http://dx.doi.org/10.1371/journal.pone.0113894 |